Infant Formula Lipid Composition with sn-2 Palmitic Acid
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current infant formulas do not effectively prevent obesity later in life, as they often lead to increased fat mass accumulation and decreased lean body mass, with conventional vegetable oils causing bioavailability issues and stool hardness due to palmitic acid placement in triglycerides.
Innovation Solution
A nutritional composition with a lipid component featuring triglycerides having a higher portion of palmitic acid residues esterified at the sn-2 position, combined with an optimal fatty acid profile and phospholipid coating on lipid globules, to promote healthier body composition and reduce obesity risk.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional vegetable oils with palmitic acid at sn-1 and sn-3 positions are used, then the lipid component provides basic nutritional value, but calcium bioavailability is reduced and stool hardness increases
Solution Approach 1:
The patent applies local quality by specifically modifying the position of palmitic acid residues within the triglyceride molecule. Instead of having palmitic acid at sn-1 and sn-3 positions (conventional), the invention places palmitic acid at the sn-2 position, creating a localized structural change that prevents calcium binding while maintaining overall triglyceride structure and function.
2Stability of the object's composition
If small lipid globules with protein coating are used, then a stable non-creaming emulsion is achieved, but obesity prevention effects are limited
Solution Approach 1:
The patent applies parameter changes by modifying the coating composition parameter of the lipid globules. Instead of protein coating (conventional), the invention uses phospholipid coating, which fundamentally changes the surface properties of the globules. This parameter change maintains emulsion stability while adding obesity prevention effects, as phospholipids influence lipid metabolism and body composition programming.
3Use of energy by moving object
If triglycerides with increased palmitic acid at sn-2 position are administered, then fat absorption is increased, but fat mass accumulation later in life is reduced
Solution Approach 1:
The patent applies preliminary action by administering triglycerides with palmitic acid at sn-2 position during the critical early life period (infancy and childhood). This preliminary nutritional intervention programs metabolic pathways and body composition development before the onset of obesity risk. The early exposure to this specific lipid structure creates long-term metabolic effects that reduce fat mass accumulation even when transitioning to Western-style diets later in life.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The described composition results in reduced fat mass accumulation, increased lean body mass, and improved body composition by programming the body to resist obesogenic diets, even when transitioning to a Western-style diet later in life.
Implementation Method 1
The pancreatic lipases specifically hydrolyse the palmitic acid
Implementation Method 2
the surface of the lipid globules is coated mainly with proteins
Data Source
AI summary
The invention relates to the use of specifically designed lipid component with optimal fatty acid profile, an enhanced portion of the palmitic acid residues in the sn-2 position and present as lipid globules with a phospholipid coating for an early in life diet for improving the development of a healthy body composition, in particular prevention of obesity,later in life.